Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches

Sudin Bhattacharya1, Lisl K M Shoda, Qiang Zhang

  • 1Institute for Chemical Safety Sciences, The Hamner Institutes for Health Sciences Research Triangle Park, NC, USA.

Frontiers in Physiology
|December 19, 2012
PubMed

Insights

Computational systems biology offers new ways to study chemical and drug toxicity, focusing on "toxicity pathways." These methods enable better prediction of liver toxicity from environmental contaminants and drugs.

Area of Science:

  • Computational systems biology
  • Toxicology
  • Network biology

Background:

  • The 2007 National Academies of Science report, "Toxicity testing in the 21st Century: A Vision and A Strategy," proposed biologically based toxicity analysis.
  • Pathway mapping and modeling are crucial for understanding chemical and drug safety and dose-response relationships.

Purpose of the Study:

  • To provide an overview of computational systems biology approaches for studying chemical- and drug-induced toxicity.
  • To illustrate these approaches through case studies focused on liver toxicity (hepatotoxicity).

Main Methods:

  • Development of a spatial, multicellular "virtual tissue" model of the liver lobule for predicting dose-response.
  • Extraction of quantitative maps of intracellular signaling and transcriptional regulatory networks.
  • Utilizing a predictive physiological model (DILIsym™) for drug-induced liver injury (DILI).

Main Results:

  • The virtual tissue model enables quantitative, mechanistic prediction of hepatic dose-response for specific toxicity pathways (e.g., aryl hydrocarbon receptor).
  • Methods are being developed to map perturbed intracellular networks using multi-omics data.
  • The DILIsym™ model provides insights into drug-induced liver injury, starting with acetaminophen.

Conclusions:

  • Computational systems biology offers powerful, multi-scale modeling approaches to understand complex toxicity mechanisms.
  • These methods advance the vision for a more biologically informed approach to chemical and drug safety assessment.
  • Predictive models like DILIsym™ are essential for evaluating drug safety and mitigating risks in clinical development.

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...